Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 211.47 billion as of May 13, 2025. Its market cap has increased by 53.15% in one year.

Market Cap

211.47B

Enterprise Value

327.37B

Revenue

67.38B

Ranking

n/a

PE Ratio

n/a

Stock Price

669.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 211.47B, an increase of 6,548.95%. That is a compound annual growth rate of 15.36%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	208.05B	59.07%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.02T
Celltrion	33.69T
ALTEOGEN	18.39T
Yuhan	8,026.78B
HLB Co., Ltd.	7,581.42B
SK Biopharmaceuticals	7,079.52B
PharmaResearch	4,171.44B
Peptron	3,872.02B

Market Cap Rankings